{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3567, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de075-a489-74d4-a50c-d568738d8ab3", "docSlug": "c8560b8b093c98748191ba9bd36dd527", "documentTitle": "Hyzon | Investor Conference Presentation Deck | 24 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "timeline", "function": "plan_implementation", "notes": "The slide uses a horizontal timeline to track progress against specific technical and production milestones.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a489-74d4-a50c-d568738d8ab3/7", "deckHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3", "deckAnchorHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3#slide-7", "loopMatches": [ { "to": 9, "from": 6, "name": "Zoom In", "slug": "06-zoom-in", "bestFor": "Technical deep-dives, case studies, detailed analysis", "matchId": "cbaf51e3-2aa4-4d80-bccb-1774adfa757c", "evidence": "The document provides a detailed comparison of Hyzon's technology with traditional approaches.", "position": 0, "objective": "To provide a detailed look at Hyzon's single stack 200 kW FCS technology and its benefits.", "structure": "The Big Picture -> Key Area of Focus -> Specific Detail -> Implication", "confidence": 0.7, "description": "Start broad, then progressively focus on specific details that prove your point" } ], "arcBeatMatches": [ { "to": 9, "from": 6, "beatId": "3d402e6a-818e-486e-99f3-47bb7f356584", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents Hyzon's single stack 200 kW FCS technology and capital-light model as a solution to the industry challenges.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a489-74d4-a50c-d568738d8ab3", "docSlug": "c8560b8b093c98748191ba9bd36dd527", "documentTitle": "Hyzon | Investor Conference Presentation Deck | 24 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "propose_solution", "function": "present_solution", "notes": "Uses a process flow diagram to explain the capital-light manufacturing strategy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a489-74d4-a50c-d568738d8ab3/8", "deckHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3", "deckAnchorHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3#slide-8", "loopMatches": [ { "to": 9, "from": 6, "name": "Zoom In", "slug": "06-zoom-in", "bestFor": "Technical deep-dives, case studies, detailed analysis", "matchId": "cbaf51e3-2aa4-4d80-bccb-1774adfa757c", "evidence": "The document provides a detailed comparison of Hyzon's technology with traditional approaches.", "position": 0, "objective": "To provide a detailed look at Hyzon's single stack 200 kW FCS technology and its benefits.", "structure": "The Big Picture -> Key Area of Focus -> Specific Detail -> Implication", "confidence": 0.7, "description": "Start broad, then progressively focus on specific details that prove your point" } ], "arcBeatMatches": [ { "to": 9, "from": 6, "beatId": "3d402e6a-818e-486e-99f3-47bb7f356584", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents Hyzon's single stack 200 kW FCS technology and capital-light model as a solution to the industry challenges.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a489-74d4-a50c-d568738d8ab3", "docSlug": "c8560b8b093c98748191ba9bd36dd527", "documentTitle": "Hyzon | Investor Conference Presentation Deck | 24 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "revenue_buildup", "function": "analyze_data", "notes": "The slide uses a stacked bar chart to illustrate cost structure and contribution margin for different fuel cell configurations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a489-74d4-a50c-d568738d8ab3/9", "deckHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3", "deckAnchorHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3#slide-9", "loopMatches": [ { "to": 9, "from": 6, "name": "Zoom In", "slug": "06-zoom-in", "bestFor": "Technical deep-dives, case studies, detailed analysis", "matchId": "cbaf51e3-2aa4-4d80-bccb-1774adfa757c", "evidence": "The document provides a detailed comparison of Hyzon's technology with traditional approaches.", "position": 0, "objective": "To provide a detailed look at Hyzon's single stack 200 kW FCS technology and its benefits.", "structure": "The Big Picture -> Key Area of Focus -> Specific Detail -> Implication", "confidence": 0.7, "description": "Start broad, then progressively focus on specific details that prove your point" } ], "arcBeatMatches": [ { "to": 9, "from": 6, "beatId": "3d402e6a-818e-486e-99f3-47bb7f356584", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents Hyzon's single stack 200 kW FCS technology and capital-light model as a solution to the industry challenges.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a489-74d4-a50c-d568738d8ab3", "docSlug": "c8560b8b093c98748191ba9bd36dd527", "documentTitle": "Hyzon | Investor Conference Presentation Deck | 24 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "before_after", "function": "present_solution", "notes": "Uses stacked bar charts to illustrate cost and working capital reduction.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a489-74d4-a50c-d568738d8ab3/10", "deckHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3", "deckAnchorHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3#slide-10", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a489-74d4-a50c-d568738d8ab3", "docSlug": "c8560b8b093c98748191ba9bd36dd527", "documentTitle": "Hyzon | Investor Conference Presentation Deck | 24 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "comparison_table", "function": "quantify_opportunity", "notes": "The chart shows that at 1,000 units, FCEV cost without subsidy ($1.33) is approaching diesel parity ($1.31).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a489-74d4-a50c-d568738d8ab3/11", "deckHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3", "deckAnchorHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3#slide-11", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a489-74d4-a50c-d568738d8ab3", "docSlug": "c8560b8b093c98748191ba9bd36dd527", "documentTitle": "Hyzon | Investor Conference Presentation Deck | 24 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide outlines a progression from Pilot to Ramp-up, detailing truck counts and hydrogen consumption.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a489-74d4-a50c-d568738d8ab3/12", "deckHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3", "deckAnchorHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 12, "beatId": "d8493f79-697a-4aa0-9897-6efea9addf95", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "The document presents the market opportunity in the heavy-duty trucking industry.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a489-74d4-a50c-d568738d8ab3", "docSlug": "c8560b8b093c98748191ba9bd36dd527", "documentTitle": "Hyzon | Investor Conference Presentation Deck | 24 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide uses a funnel-like progression from early engagement to contracted fleets, highlighting specific anchor customers.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a489-74d4-a50c-d568738d8ab3/13", "deckHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3", "deckAnchorHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 12, "beatId": "d8493f79-697a-4aa0-9897-6efea9addf95", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "The document presents the market opportunity in the heavy-duty trucking industry.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a489-74d4-a50c-d568738d8ab3", "docSlug": "c8560b8b093c98748191ba9bd36dd527", "documentTitle": "Hyzon | Investor Conference Presentation Deck | 24 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide uses two distinct visual comparisons: a bar-style timeline for refueling and a bubble-chart style comparison for payload efficiency.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a489-74d4-a50c-d568738d8ab3/14", "deckHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3", "deckAnchorHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 12, "beatId": "d8493f79-697a-4aa0-9897-6efea9addf95", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Size", "beatSlug": "sequoia-pitch-market-size", "evidence": "The document presents the market opportunity in the heavy-duty trucking industry.", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a489-74d4-a50c-d568738d8ab3", "docSlug": "c8560b8b093c98748191ba9bd36dd527", "documentTitle": "Hyzon | Investor Conference Presentation Deck | 24 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "comparison_table", "function": "compare_peers", "notes": "The slide uses a combination of infographic icons for load comparison and a bar chart for infrastructure requirements.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a489-74d4-a50c-d568738d8ab3/15", "deckHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3", "deckAnchorHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3#slide-15", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a489-74d4-a50c-d568738d8ab3", "docSlug": "c8560b8b093c98748191ba9bd36dd527", "documentTitle": "Hyzon | Investor Conference Presentation Deck | 24 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "other", "function": "present_solution", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a489-74d4-a50c-d568738d8ab3/16", "deckHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3", "deckAnchorHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3#slide-16", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a489-74d4-a50c-d568738d8ab3", "docSlug": "c8560b8b093c98748191ba9bd36dd527", "documentTitle": "Hyzon | Investor Conference Presentation Deck | 24 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "other", "function": "illustrate_case", "notes": "Features two photos of the same truck model in different environments (indoor facility and outdoor track).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a489-74d4-a50c-d568738d8ab3/17", "deckHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3", "deckAnchorHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a489-74d4-a50c-d568738d8ab3", "docSlug": "c8560b8b093c98748191ba9bd36dd527", "documentTitle": "Hyzon | Investor Conference Presentation Deck | 24 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The chart uses a waterfall-like structure to aggregate market segments into a total addressable market.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a489-74d4-a50c-d568738d8ab3/18", "deckHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3", "deckAnchorHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3#slide-18", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a489-74d4-a50c-d568738d8ab3", "docSlug": "c8560b8b093c98748191ba9bd36dd527", "documentTitle": "Hyzon | Investor Conference Presentation Deck | 24 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "comparison_table", "function": "present_framework", "notes": "The table uses checkmarks to indicate capability/applicability across different feedstock types (MSW, RNG, Industrial Gas, Biomass, Solar/Wind).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a489-74d4-a50c-d568738d8ab3/19", "deckHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3", "deckAnchorHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a489-74d4-a50c-d568738d8ab3", "docSlug": "c8560b8b093c98748191ba9bd36dd527", "documentTitle": "Hyzon | Investor Conference Presentation Deck | 24 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a489-74d4-a50c-d568738d8ab3/20", "deckHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3", "deckAnchorHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3#slide-20", "loopMatches": [], "arcBeatMatches": [ { "to": 24, "from": 20, "beatId": "a2204528-59e4-4e56-86a3-623bb7773563", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "The document presents the company's financial performance and guidance.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a489-74d4-a50c-d568738d8ab3", "docSlug": "c8560b8b093c98748191ba9bd36dd527", "documentTitle": "Hyzon | Investor Conference Presentation Deck | 24 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The table includes revenue, operating expenses, net income, EPS, Adjusted EBITDA, CapEx, cash position, and headcount.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a489-74d4-a50c-d568738d8ab3/21", "deckHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3", "deckAnchorHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3#slide-21", "loopMatches": [], "arcBeatMatches": [ { "to": 24, "from": 20, "beatId": "a2204528-59e4-4e56-86a3-623bb7773563", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "The document presents the company's financial performance and guidance.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a489-74d4-a50c-d568738d8ab3", "docSlug": "c8560b8b093c98748191ba9bd36dd527", "documentTitle": "Hyzon | Investor Conference Presentation Deck | 24 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table provides a detailed breakdown of non-GAAP financial adjustments.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a489-74d4-a50c-d568738d8ab3/22", "deckHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3", "deckAnchorHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3#slide-22", "loopMatches": [], "arcBeatMatches": [ { "to": 24, "from": 20, "beatId": "a2204528-59e4-4e56-86a3-623bb7773563", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "The document presents the company's financial performance and guidance.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a489-74d4-a50c-d568738d8ab3", "docSlug": "c8560b8b093c98748191ba9bd36dd527", "documentTitle": "Hyzon | Investor Conference Presentation Deck | 24 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes a footnote regarding the exclusion of $8.4 million Orten acquisition cancellation in 3Q 2022.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a489-74d4-a50c-d568738d8ab3/23", "deckHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3", "deckAnchorHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3#slide-23", "loopMatches": [], "arcBeatMatches": [ { "to": 24, "from": 20, "beatId": "a2204528-59e4-4e56-86a3-623bb7773563", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "The document presents the company's financial performance and guidance.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a489-74d4-a50c-d568738d8ab3", "docSlug": "c8560b8b093c98748191ba9bd36dd527", "documentTitle": "Hyzon | Investor Conference Presentation Deck | 24 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes footnotes regarding legal contingencies and SEC settlements.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a489-74d4-a50c-d568738d8ab3/24", "deckHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3", "deckAnchorHref": "/decks/019de075-a489-74d4-a50c-d568738d8ab3#slide-24", "loopMatches": [], "arcBeatMatches": [ { "to": 24, "from": 20, "beatId": "a2204528-59e4-4e56-86a3-623bb7773563", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Financials", "beatSlug": "sequoia-pitch-financials", "evidence": "The document presents the company's financial performance and guidance.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a527-726e-8ca0-68cd0a0bc055", "docSlug": "802aae6fa40a0a18e56b9cd7c0a31558", "documentTitle": "Hyzon | Results Presentation Deck | 19 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/yQxuWfzXJb4pW-qoresFTPRvRhkQkn4vLs0JMh4s19w/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy84MDJhYWU2ZmE0MGEwYTE4ZTU2YjljZDdjMGEzMTU1OC9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a527-726e-8ca0-68cd0a0bc055/1", "deckHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055", "deckAnchorHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/5MZh5vWuar8AJ6IdIR47Mtpx1Rio0VM7EZHYhhAMMTM/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy84MDJhYWU2ZmE0MGEwYTE4ZTU2YjljZDdjMGEzMTU1OC9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/gUs_6SL9uSAZJXoXADTTARPTzEZVOFno5liaQpTqp3Y/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy84MDJhYWU2ZmE0MGEwYTE4ZTU2YjljZDdjMGEzMTU1OC9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/ZaMiH98UFFdhlHlmYntyOvnB6ILOV8KMmc6sHLvtAxw/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy84MDJhYWU2ZmE0MGEwYTE4ZTU2YjljZDdjMGEzMTU1OC9wMDAxLnBuZw" }, { "docId": "019de075-a527-726e-8ca0-68cd0a0bc055", "docSlug": "802aae6fa40a0a18e56b9cd7c0a31558", "documentTitle": "Hyzon | Results Presentation Deck | 19 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a527-726e-8ca0-68cd0a0bc055/2", "deckHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055", "deckAnchorHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a527-726e-8ca0-68cd0a0bc055", "docSlug": "802aae6fa40a0a18e56b9cd7c0a31558", "documentTitle": "Hyzon | Results Presentation Deck | 19 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "executive_summary", "function": "summarize", "notes": "Includes both operational milestones and financial results/guidance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a527-726e-8ca0-68cd0a0bc055/3", "deckHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055", "deckAnchorHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 3, "beatId": "f2fa1c4f-dcc9-45d6-9093-2cac136ce8b3", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Humble Origins", "beatSlug": "rags-to-riches-humble-origins", "evidence": "The presentation starts with an overview of Hyzon's current state (p3: Q2 2023 At a Glance, p5: Hyzon Motors at a Glance).", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a527-726e-8ca0-68cd0a0bc055", "docSlug": "802aae6fa40a0a18e56b9cd7c0a31558", "documentTitle": "Hyzon | Results Presentation Deck | 19 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a527-726e-8ca0-68cd0a0bc055/4", "deckHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055", "deckAnchorHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 3, "beatId": "f2fa1c4f-dcc9-45d6-9093-2cac136ce8b3", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Humble Origins", "beatSlug": "rags-to-riches-humble-origins", "evidence": "The presentation starts with an overview of Hyzon's current state (p3: Q2 2023 At a Glance, p5: Hyzon Motors at a Glance).", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a527-726e-8ca0-68cd0a0bc055", "docSlug": "802aae6fa40a0a18e56b9cd7c0a31558", "documentTitle": "Hyzon | Results Presentation Deck | 19 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a three-row structure to categorize company assets: technology, product, and ecosystem.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a527-726e-8ca0-68cd0a0bc055/5", "deckHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055", "deckAnchorHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 3, "beatId": "f2fa1c4f-dcc9-45d6-9093-2cac136ce8b3", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Humble Origins", "beatSlug": "rags-to-riches-humble-origins", "evidence": "The presentation starts with an overview of Hyzon's current state (p3: Q2 2023 At a Glance, p5: Hyzon Motors at a Glance).", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a527-726e-8ca0-68cd0a0bc055", "docSlug": "802aae6fa40a0a18e56b9cd7c0a31558", "documentTitle": "Hyzon | Results Presentation Deck | 19 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "before_after", "function": "present_solution", "notes": "The slide uses a process-like flow to connect technical features to quantitative performance outcomes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a527-726e-8ca0-68cd0a0bc055/6", "deckHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055", "deckAnchorHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 7, "from": 6, "beatId": "a25b3e24-af1f-41a7-9ee5-bb1dc25e9924", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Early Struggles", "beatSlug": "rags-to-riches-early-struggles", "evidence": "The presentation then highlights Hyzon's challenges and progress in its single stack 200 kW FCS technology (p6: Hyzon's single stack 200 kW FCS shows significant benefits, p7: On Track to Driving Hyzon’s Single Stack 200kW FCS Technology to Commercialization).", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a527-726e-8ca0-68cd0a0bc055", "docSlug": "802aae6fa40a0a18e56b9cd7c0a31558", "documentTitle": "Hyzon | Results Presentation Deck | 19 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "timeline", "function": "plan_implementation", "notes": "The slide uses a horizontal timeline to track progress against specific technical and production milestones.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a527-726e-8ca0-68cd0a0bc055/7", "deckHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055", "deckAnchorHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 7, "from": 6, "beatId": "a25b3e24-af1f-41a7-9ee5-bb1dc25e9924", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Early Struggles", "beatSlug": "rags-to-riches-early-struggles", "evidence": "The presentation then highlights Hyzon's challenges and progress in its single stack 200 kW FCS technology (p6: Hyzon's single stack 200 kW FCS shows significant benefits, p7: On Track to Driving Hyzon’s Single Stack 200kW FCS Technology to Commercialization).", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a527-726e-8ca0-68cd0a0bc055", "docSlug": "802aae6fa40a0a18e56b9cd7c0a31558", "documentTitle": "Hyzon | Results Presentation Deck | 19 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "customer_journey", "function": "analyze_data", "notes": "The slide uses a funnel-like progression for the pipeline and highlights specific customer logos under the 'Contracted Fleets' stage.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a527-726e-8ca0-68cd0a0bc055/8", "deckHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055", "deckAnchorHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 12, "from": 8, "beatId": "5d740690-6bcb-4e1a-83f9-e79f47292f67", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Rising Success", "beatSlug": "rags-to-riches-rising-success", "evidence": "The presentation showcases Hyzon's growing success with its active pipeline, initial anchor customers, and streamlined core platforms (p8: Active and Progressing Pipeline, p11: Three Streamlined and Region-Specific Core Platforms Today).", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a527-726e-8ca0-68cd0a0bc055", "docSlug": "802aae6fa40a0a18e56b9cd7c0a31558", "documentTitle": "Hyzon | Results Presentation Deck | 19 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "propose_solution", "function": "present_solution", "notes": "Uses a process flow diagram to illustrate the transition from subassembly modules to final assembly and customer experience.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a527-726e-8ca0-68cd0a0bc055/9", "deckHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055", "deckAnchorHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 12, "from": 8, "beatId": "5d740690-6bcb-4e1a-83f9-e79f47292f67", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Rising Success", "beatSlug": "rags-to-riches-rising-success", "evidence": "The presentation showcases Hyzon's growing success with its active pipeline, initial anchor customers, and streamlined core platforms (p8: Active and Progressing Pipeline, p11: Three Streamlined and Region-Specific Core Platforms Today).", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a527-726e-8ca0-68cd0a0bc055", "docSlug": "802aae6fa40a0a18e56b9cd7c0a31558", "documentTitle": "Hyzon | Results Presentation Deck | 19 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide outlines a strategic progression from pilot to full ramp-up, supported by specific operational metrics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a527-726e-8ca0-68cd0a0bc055/10", "deckHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055", "deckAnchorHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 12, "from": 8, "beatId": "5d740690-6bcb-4e1a-83f9-e79f47292f67", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Rising Success", "beatSlug": "rags-to-riches-rising-success", "evidence": "The presentation showcases Hyzon's growing success with its active pipeline, initial anchor customers, and streamlined core platforms (p8: Active and Progressing Pipeline, p11: Three Streamlined and Region-Specific Core Platforms Today).", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a527-726e-8ca0-68cd0a0bc055", "docSlug": "802aae6fa40a0a18e56b9cd7c0a31558", "documentTitle": "Hyzon | Results Presentation Deck | 19 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "other", "function": "present_framework", "notes": "Uses a map-based layout to associate product types with regional progress.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a527-726e-8ca0-68cd0a0bc055/11", "deckHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055", "deckAnchorHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055#slide-11", "loopMatches": [], "arcBeatMatches": [ { "to": 12, "from": 8, "beatId": "5d740690-6bcb-4e1a-83f9-e79f47292f67", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Rising Success", "beatSlug": "rags-to-riches-rising-success", "evidence": "The presentation showcases Hyzon's growing success with its active pipeline, initial anchor customers, and streamlined core platforms (p8: Active and Progressing Pipeline, p11: Three Streamlined and Region-Specific Core Platforms Today).", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a527-726e-8ca0-68cd0a0bc055", "docSlug": "802aae6fa40a0a18e56b9cd7c0a31558", "documentTitle": "Hyzon | Results Presentation Deck | 19 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses icons to categorize milestones into Organization, Fuel cell, and Vehicle.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a527-726e-8ca0-68cd0a0bc055/12", "deckHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055", "deckAnchorHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 12, "from": 8, "beatId": "5d740690-6bcb-4e1a-83f9-e79f47292f67", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Rising Success", "beatSlug": "rags-to-riches-rising-success", "evidence": "The presentation showcases Hyzon's growing success with its active pipeline, initial anchor customers, and streamlined core platforms (p8: Active and Progressing Pipeline, p11: Three Streamlined and Region-Specific Core Platforms Today).", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a527-726e-8ca0-68cd0a0bc055", "docSlug": "802aae6fa40a0a18e56b9cd7c0a31558", "documentTitle": "Hyzon | Results Presentation Deck | 19 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a matrix-like structure to map strategic initiatives against time and recurrence.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a527-726e-8ca0-68cd0a0bc055/13", "deckHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055", "deckAnchorHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 13, "from": 13, "beatId": "b9b91bab-0935-4f54-852b-efb13013ea45", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "The Breakthrough", "beatSlug": "rags-to-riches-the-breakthrough", "evidence": "The presentation highlights Hyzon's strategic path forward (p13: Strategic Path Forward).", "position": 3, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a527-726e-8ca0-68cd0a0bc055", "docSlug": "802aae6fa40a0a18e56b9cd7c0a31558", "documentTitle": "Hyzon | Results Presentation Deck | 19 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a527-726e-8ca0-68cd0a0bc055/14", "deckHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055", "deckAnchorHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 19, "from": 14, "beatId": "bc4a3e5a-7ff9-48d7-8801-152b4ba24278", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Ultimate Achievement", "beatSlug": "rags-to-riches-ultimate-achievement", "evidence": "The presentation concludes with Hyzon's Q2 financial performance, guidance, and appendix (p14: Q2 Financial Performance & Guidance, p15-19: Financials and Appendix).", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a527-726e-8ca0-68cd0a0bc055", "docSlug": "802aae6fa40a0a18e56b9cd7c0a31558", "documentTitle": "Hyzon | Results Presentation Deck | 19 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The table includes both GAAP financial metrics and supplemental non-GAAP/operational data.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a527-726e-8ca0-68cd0a0bc055/15", "deckHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055", "deckAnchorHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055#slide-15", "loopMatches": [], "arcBeatMatches": [ { "to": 19, "from": 14, "beatId": "bc4a3e5a-7ff9-48d7-8801-152b4ba24278", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Ultimate Achievement", "beatSlug": "rags-to-riches-ultimate-achievement", "evidence": "The presentation concludes with Hyzon's Q2 financial performance, guidance, and appendix (p14: Q2 Financial Performance & Guidance, p15-19: Financials and Appendix).", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a527-726e-8ca0-68cd0a0bc055", "docSlug": "802aae6fa40a0a18e56b9cd7c0a31558", "documentTitle": "Hyzon | Results Presentation Deck | 19 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The data shows a significant spike in legal/consulting/accounting fees in Q2 2023 due to SEC investigation accruals.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a527-726e-8ca0-68cd0a0bc055/16", "deckHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055", "deckAnchorHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055#slide-16", "loopMatches": [], "arcBeatMatches": [ { "to": 19, "from": 14, "beatId": "bc4a3e5a-7ff9-48d7-8801-152b4ba24278", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Ultimate Achievement", "beatSlug": "rags-to-riches-ultimate-achievement", "evidence": "The presentation concludes with Hyzon's Q2 financial performance, guidance, and appendix (p14: Q2 Financial Performance & Guidance, p15-19: Financials and Appendix).", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a527-726e-8ca0-68cd0a0bc055", "docSlug": "802aae6fa40a0a18e56b9cd7c0a31558", "documentTitle": "Hyzon | Results Presentation Deck | 19 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The table includes footnotes explaining specific adjustments to the figures.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a527-726e-8ca0-68cd0a0bc055/17", "deckHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055", "deckAnchorHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055#slide-17", "loopMatches": [], "arcBeatMatches": [ { "to": 19, "from": 14, "beatId": "bc4a3e5a-7ff9-48d7-8801-152b4ba24278", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Ultimate Achievement", "beatSlug": "rags-to-riches-ultimate-achievement", "evidence": "The presentation concludes with Hyzon's Q2 financial performance, guidance, and appendix (p14: Q2 Financial Performance & Guidance, p15-19: Financials and Appendix).", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a527-726e-8ca0-68cd0a0bc055", "docSlug": "802aae6fa40a0a18e56b9cd7c0a31558", "documentTitle": "Hyzon | Results Presentation Deck | 19 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "appendix", "function": "appendix", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a527-726e-8ca0-68cd0a0bc055/18", "deckHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055", "deckAnchorHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055#slide-18", "loopMatches": [], "arcBeatMatches": [ { "to": 19, "from": 14, "beatId": "bc4a3e5a-7ff9-48d7-8801-152b4ba24278", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Ultimate Achievement", "beatSlug": "rags-to-riches-ultimate-achievement", "evidence": "The presentation concludes with Hyzon's Q2 financial performance, guidance, and appendix (p14: Q2 Financial Performance & Guidance, p15-19: Financials and Appendix).", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a527-726e-8ca0-68cd0a0bc055", "docSlug": "802aae6fa40a0a18e56b9cd7c0a31558", "documentTitle": "Hyzon | Results Presentation Deck | 19 slides", "authorId": "hyzon", "authorName": "Hyzon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table includes adjustments for fair value changes, stock-based compensation, and legal/regulatory matters.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a527-726e-8ca0-68cd0a0bc055/19", "deckHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055", "deckAnchorHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055#slide-19", "loopMatches": [], "arcBeatMatches": [ { "to": 19, "from": 14, "beatId": "bc4a3e5a-7ff9-48d7-8801-152b4ba24278", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Ultimate Achievement", "beatSlug": "rags-to-riches-ultimate-achievement", "evidence": "The presentation concludes with Hyzon's Q2 financial performance, guidance, and appendix (p14: Q2 Financial Performance & Guidance, p15-19: Financials and Appendix).", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "docSlug": "2296286e07283457e97b21dc9ce59469", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/a5WjJRMGsUX3RmUlaRbyFsLkH5cg0tFuN05gxY1jbaY/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yMjk2Mjg2ZTA3MjgzNDU3ZTk3YjIxZGM5Y2U1OTQ2OS9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/1", "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/hkd0eF1LXsUTUENcxls_nV2iix8nl_j9iPVeXGOVQOU/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yMjk2Mjg2ZTA3MjgzNDU3ZTk3YjIxZGM5Y2U1OTQ2OS9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/Jefjr9Wx7IiIecNnElpwKVLTfjBOH8VhlY_aPM7lzoY/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yMjk2Mjg2ZTA3MjgzNDU3ZTk3YjIxZGM5Y2U1OTQ2OS9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/T6reQfjSKrj81Sn7ik-QtdomMOWW55rh-GpYySRf3Jg/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yMjk2Mjg2ZTA3MjgzNDU3ZTk3YjIxZGM5Y2U1OTQ2OS9wMDAxLnBuZw" }, { "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "docSlug": "2296286e07283457e97b21dc9ce59469", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/2", "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "docSlug": "2296286e07283457e97b21dc9ce59469", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "executive_summary", "function": "summarize", "notes": "The slide highlights two distinct pipelines: TSTx (Tissue Specific Therapeutics) and NextGen CAR-T.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/3", "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 3, "beatId": "250e6c83-38a5-4886-bb70-804cf4659e47", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The presentation identifies the problem and the market opportunity.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "docSlug": "2296286e07283457e97b21dc9ce59469", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide uses a wave-like visual to represent market segments and their associated financial opportunities.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/4", "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-4", "loopMatches": [ { "to": 9, "from": 4, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "5f2e0111-b5c3-4127-8874-dd9c86260d92", "evidence": "The presentation highlights the market opportunity and the limitations of current treatments.", "position": 0, "objective": "What are the consequences of not addressing the unmet medical needs?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 5, "from": 3, "beatId": "250e6c83-38a5-4886-bb70-804cf4659e47", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The presentation identifies the problem and the market opportunity.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "docSlug": "2296286e07283457e97b21dc9ce59469", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "roadmap", "function": "show_traction", "notes": "The table uses a standard pharmaceutical pipeline format, categorizing by clinical vs preclinical status and therapy type (CAR-T vs TSTx).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/5", "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-5", "loopMatches": [ { "to": 9, "from": 4, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "5f2e0111-b5c3-4127-8874-dd9c86260d92", "evidence": "The presentation highlights the market opportunity and the limitations of current treatments.", "position": 0, "objective": "What are the consequences of not addressing the unmet medical needs?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 5, "from": 3, "beatId": "250e6c83-38a5-4886-bb70-804cf4659e47", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem (Identify pain)", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The presentation identifies the problem and the market opportunity.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "docSlug": "2296286e07283457e97b21dc9ce59469", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "traction", "function": "show_traction", "notes": "The slide uses a grouped bar chart to compare clinical outcomes across different patient segments (No BCMA, Yes BCMA, Overall).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/6", "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-6", "loopMatches": [ { "to": 9, "from": 4, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "5f2e0111-b5c3-4127-8874-dd9c86260d92", "evidence": "The presentation highlights the market opportunity and the limitations of current treatments.", "position": 0, "objective": "What are the consequences of not addressing the unmet medical needs?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 9, "from": 6, "beatId": "5027be93-535f-449a-9c55-44f893156c27", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The presentation highlights the limitations of current treatments.", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "docSlug": "2296286e07283457e97b21dc9ce59469", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "Includes detailed source citations in the footer.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/7", "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-7", "loopMatches": [ { "to": 9, "from": 4, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "5f2e0111-b5c3-4127-8874-dd9c86260d92", "evidence": "The presentation highlights the market opportunity and the limitations of current treatments.", "position": 0, "objective": "What are the consequences of not addressing the unmet medical needs?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 9, "from": 6, "beatId": "5027be93-535f-449a-9c55-44f893156c27", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The presentation highlights the limitations of current treatments.", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "docSlug": "2296286e07283457e97b21dc9ce59469", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "traction", "function": "show_traction", "notes": "Includes detailed source citations in the footer.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/8", "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-8", "loopMatches": [ { "to": 9, "from": 4, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "5f2e0111-b5c3-4127-8874-dd9c86260d92", "evidence": "The presentation highlights the market opportunity and the limitations of current treatments.", "position": 0, "objective": "What are the consequences of not addressing the unmet medical needs?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 9, "from": 6, "beatId": "5027be93-535f-449a-9c55-44f893156c27", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The presentation highlights the limitations of current treatments.", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "docSlug": "2296286e07283457e97b21dc9ce59469", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a two-column layout to separate milestones by drug candidate.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/9", "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-9", "loopMatches": [ { "to": 9, "from": 4, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "5f2e0111-b5c3-4127-8874-dd9c86260d92", "evidence": "The presentation highlights the market opportunity and the limitations of current treatments.", "position": 0, "objective": "What are the consequences of not addressing the unmet medical needs?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 9, "from": 6, "beatId": "5027be93-535f-449a-9c55-44f893156c27", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate (Make it worse)", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The presentation highlights the limitations of current treatments.", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "docSlug": "2296286e07283457e97b21dc9ce59469", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a side-by-side comparison of two proprietary technology platforms.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/10", "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-10", "loopMatches": [ { "to": 16, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "d3ed2b4b-7476-486a-bc9e-587ba67669a2", "evidence": "The presentation presents clinical results and data to support the solutions.", "position": 1, "objective": "What are the potential benefits of Immix Biopharma's solutions?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 16, "from": 10, "beatId": "ec348a34-4a83-4f17-b0f0-268fe2d31e3a", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation presents Immix Biopharma's solutions and clinical results.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "docSlug": "2296286e07283457e97b21dc9ce59469", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "transition", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/11", "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-11", "loopMatches": [ { "to": 16, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "d3ed2b4b-7476-486a-bc9e-587ba67669a2", "evidence": "The presentation presents clinical results and data to support the solutions.", "position": 1, "objective": "What are the potential benefits of Immix Biopharma's solutions?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 16, "from": 10, "beatId": "ec348a34-4a83-4f17-b0f0-268fe2d31e3a", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation presents Immix Biopharma's solutions and clinical results.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "docSlug": "2296286e07283457e97b21dc9ce59469", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a matrix structure to compare clinical outcomes against three key value propositions.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/12", "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-12", "loopMatches": [ { "to": 16, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "d3ed2b4b-7476-486a-bc9e-587ba67669a2", "evidence": "The presentation presents clinical results and data to support the solutions.", "position": 1, "objective": "What are the potential benefits of Immix Biopharma's solutions?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 16, "from": 10, "beatId": "ec348a34-4a83-4f17-b0f0-268fe2d31e3a", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation presents Immix Biopharma's solutions and clinical results.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "docSlug": "2296286e07283457e97b21dc9ce59469", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "solution", "function": "present_solution", "notes": "Includes comparative bar charts and flow cytometry data.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/13", "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-13", "loopMatches": [ { "to": 16, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "d3ed2b4b-7476-486a-bc9e-587ba67669a2", "evidence": "The presentation presents clinical results and data to support the solutions.", "position": 1, "objective": "What are the potential benefits of Immix Biopharma's solutions?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 16, "from": 10, "beatId": "ec348a34-4a83-4f17-b0f0-268fe2d31e3a", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation presents Immix Biopharma's solutions and clinical results.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "docSlug": "2296286e07283457e97b21dc9ce59469", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "why_now", "function": "argue_timing", "notes": "Includes a comparison table of clinical outcomes (ORR/CR) for NXC-201 vs competitors.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/14", "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-14", "loopMatches": [ { "to": 16, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "d3ed2b4b-7476-486a-bc9e-587ba67669a2", "evidence": "The presentation presents clinical results and data to support the solutions.", "position": 1, "objective": "What are the potential benefits of Immix Biopharma's solutions?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 16, "from": 10, "beatId": "ec348a34-4a83-4f17-b0f0-268fe2d31e3a", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation presents Immix Biopharma's solutions and clinical results.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "docSlug": "2296286e07283457e97b21dc9ce59469", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/15", "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-15", "loopMatches": [ { "to": 16, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "d3ed2b4b-7476-486a-bc9e-587ba67669a2", "evidence": "The presentation presents clinical results and data to support the solutions.", "position": 1, "objective": "What are the potential benefits of Immix Biopharma's solutions?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 16, "from": 10, "beatId": "ec348a34-4a83-4f17-b0f0-268fe2d31e3a", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation presents Immix Biopharma's solutions and clinical results.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "docSlug": "2296286e07283457e97b21dc9ce59469", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "traction", "function": "show_traction", "notes": "The slide compares two disease indications side-by-side with clinical metrics and competitive market context.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/16", "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-16", "loopMatches": [ { "to": 16, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "d3ed2b4b-7476-486a-bc9e-587ba67669a2", "evidence": "The presentation presents clinical results and data to support the solutions.", "position": 1, "objective": "What are the potential benefits of Immix Biopharma's solutions?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 16, "from": 10, "beatId": "ec348a34-4a83-4f17-b0f0-268fe2d31e3a", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The presentation presents Immix Biopharma's solutions and clinical results.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "docSlug": "2296286e07283457e97b21dc9ce59469", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The table uses a red dashed box to highlight the key clinical data rows (ORR, CR, ICANS, CRS).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/17", "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "docSlug": "2296286e07283457e97b21dc9ce59469", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "traction", "function": "show_traction", "notes": "The chart demonstrates deepening clinical responses over time, a key indicator of therapeutic efficacy in oncology trials.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/18", "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-18", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "docSlug": "2296286e07283457e97b21dc9ce59469", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The slide uses a red dashed box to highlight the key efficacy metrics for comparison.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/19", "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "docSlug": "2296286e07283457e97b21dc9ce59469", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "appendix_data", "function": "analyze_data", "notes": "The table displays clinical trial data for NXC-201, including toxicity management metrics like Tocilizumab and Dexamethasone usage.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/20", "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-20", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "docSlug": "2296286e07283457e97b21dc9ce59469", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "peer_benchmark", "function": "compare_peers", "notes": "The slide highlights specific safety data points for two dosage groups (100x10^6 and 300x10^6 cells).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/21", "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "docSlug": "2296286e07283457e97b21dc9ce59469", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a structured table-like layout to map clinical progress against specific disease indications.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/22", "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "docSlug": "2296286e07283457e97b21dc9ce59469", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-08-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "appendix_methodology", "function": "plan_implementation", "notes": "The diagram illustrates a dose escalation process leading to the RP2D.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/23", "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0", "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-23", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }